Silvia M. Baio
About
In The Last Decade
Silvia M. Baio
16 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 45
- Epidemiology 745
- Oncology 679
- Neurology 455
- Radiology, Nuclear Medicine and Imaging 383
- Cancer Research 139
Countries citing papers authored by Silvia M. Baio
This map shows the geographic impact of Silvia M. Baio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia M. Baio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia M. Baio more than expected).
Fields of papers citing papers by Silvia M. Baio
This network shows the impact of papers produced by Silvia M. Baio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia M. Baio. The network helps show where Silvia M. Baio may publish in the future.
Co-authorship network of co-authors of Silvia M. Baio
This figure shows the co-authorship network connecting the top 25 collaborators of Silvia M. Baio. A scholar is included among the top collaborators of Silvia M. Baio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia M. Baio. Silvia M. Baio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Feasibility of lymphoscintigraphy for sentinel node identification after neo-adjuvant therapy. | PubMed | Giovanni Corso, Chiara Maria Grana et al. | 6 |
| 2 | Long-term results of PRRT in advanced bronchopulmonary carcinoid | European Journal of Nuclear Medicine and Molecular Imaging | Annapaola Mariniello, Lisa Bodei et al. | 88 |
| 3 | Yttrium-labelled peptides for therapy of NET | European Journal of Nuclear Medicine and Molecular Imaging | Lisa Bodei, Marta Cremonesi et al. | 43 |
| 4 | Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study | European Journal of Nuclear Medicine and Molecular Imaging | Lisa Bodei, Marta Cremonesi et al. | 323 |
| 5 | Peptide receptor radionuclide therapy with 90Y-DOTATOC in recurrent meningioma | European Journal of Nuclear Medicine and Molecular Imaging | Mirco Bartolomei, Lisa Bodei et al. | 94 |
| 6 | Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors | European Journal of Nuclear Medicine and Molecular Imaging | Lisa Bodei, Marta Cremonesi et al. | 316 |
| 7 | Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues: ten years experience | Biomedicine & Pharmacotherapy | Lisa Bodei, Chiara Maria Grana et al. | 1 |
| 8 | Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors | European Journal of Nuclear Medicine and Molecular Imaging | Lisa Bodei, Marta Cremonesi et al. | 21 |
| 9 | Pretargeted antibody‐guided radioimmunotherapy in a child affected by resistant anaplastic large cell lymphoma | European Journal Of Haematology | Giuseppe Palumbo, Chiara Maria Grana et al. | 8 |
| 10 | Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response | The Breast | Laura Lavinia Travaini, Silvia M. Baio et al. | 9 |
| 11 | Clinical Utility of 99m Tc-Sestamibi Scintimammography in the Management of Equivocal Breast Lesions | Cancer Biotherapy and Radiopharmaceuticals | Concetta De Cicco, Giuseppe Trifirò et al. | 5 |
| 12 | Safety of sentinel node biopsy in pregnant patients with breast cancer | Annals of Oncology | Oreste Gentilini, Marta Cremonesi et al. | 153 |
| 13 | Clinical Utility of <SUP>99m</SUP>Tc-Sestamibi Scintimammography in the Management of Equivocal Breast Lesions | Cancer Biotherapy and Radiopharmaceuticals | Concetta De Cicco, Giuseppe Trifirò et al. | 1 |
| 14 | Sentinel node biopsy in male breast cancer | Nuclear Medicine Communications | Concetta De Cicco, Silvia M. Baio et al. | 53 |
| 15 | Nuclear Medicine Advances in Breast Cancer Imaging | Tumori Journal | Emilio Bombardieri, Flavio Crippa et al. | 11 |
| 16 | Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: Preliminary report of a French multicentre phase II trial | European Journal of Cancer | A. Riviére, Axel Le Cesne et al. | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.